chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My husband had been sick for three days and I started getting sick so we took COVID-19 Home Tests and we were both positive. I had a fever, I was exhausted, I had a horrible headache for a few days. I had no appetitive and I could not taste or smell anything. I called my health care provider, and they did not give me anything for my positive case. I also had this brain fog that lingered for awhile.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE SLEEP APNEA PERIPHERAL NEUROPATHY 1/17/2023 -- RECURRENCE OF SAME SYMPTOMS
Received PENTACEL on 03/10/09. On 03/11/09 which mom was changing diaper she noted L upper thigh at injection site was swollen + red and seemed to be TTT. No fever.
I relived the symptoms i went through when i got long covid for 2 months from december to end of february  a combination of chronic fatigue, loss of balance and atypical anxiety/cloudiness  this lasted from april 5th, two days after I took the vaccine to last week of may, though it got better over time
A report was received from a health care professional on 22OCT2003 concerning a 45 year old female vaccinee who experienced tenderness at the site of injection an unspecified length of time after receiving Fluvirin SC on 21OCT2003. On 21OCT2003 the vaccinee received Fluvirin SC. An unspecified length of time after receiving Fluvirin the vaccinee experienced some tenderness at the site of injection. The vaccinee had not recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 3FEB2004: Further information was received from a health care professional on 3FEB2004 indicating that the vaccinee also experienced local pain which started 2 days following vaccination. The local pain lasted for 2-3 days and the vaccinee is reported to be doing well. Cross reference with PJP200300873.
09Jan98 pt recv 1 dose vax. 21Jan98 pt exp upper respiratory infection. Pt presented to "Urgent Clinic" was tx w/prednisone. Few days later pt devel full blown varicella.
Swollen eyes. Pt contacted MD MD advised cold compress and Benadryl 50mg Q6 hours and to call 911 if breathing problems.
tenderness at injection site/localized reaction to the injection site; warmth at injection site/localized reaction to the injection site; redness at injection site/localized reaction to the injection site; malaise; inappropriate reconstitution technique; Inappropriate dose of vaccine administered; sleepness; This case was reported by a consumer via call center representative and described the occurrence of injection site tenderness in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th September 2019, the patient received Shingrix. On 24th September 2019, less than a day after receiving Shingrix, the patient experienced injection site tenderness, injection site warmth, injection site erythema, malaise, sleepiness, inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the injection site tenderness, injection site warmth, injection site erythema, malaise, sleepiness, inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   It was unknown if the reporter considered the injection site tenderness, injection site warmth, injection site erythema, malaise and sleepiness to be related to Shingrix.  Additional details were reported as follows: The vaccine was given by a medical assistant at her physician's office.  she received a call from the medical assistant and was told that she was given the adjuvent before reconstituting with antigen component (powder), which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.  Caller reported that she experienced a localized reaction to the injection site, redness, tenderness and hot to the touch, she also felt malaise and came home that evening from work and slept for 10 hours. The medical assistant informed her that she would have to retake her Shingrix injection in three weeks. Caller inquired if she should retake her Shingrix vaccine. caller was referred to her physician regarding if she should retake her Shingrix injection in three weeks, provided GSK contact number for her physician to call Medical Information department for additional information. The reporter consented to follow up.
Pelvic fracture. Surgical intervention was not recommended. She was cleared for weightbearing as tolerated. It was determined that admission to Rehab was necessary to allow for safe discharge back to home. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Patient reports pain in both arms that radiates to her back and up to her neck. She says she has difficulty lifting her arms. Said she has not experienced and fever, chills, rash, or other symptoms. Patient says her physician told her to take Benadryl, and she reports also taking Aspirin.
Pfizer 4/7/21 and 4/26/21. Positive on 1/25/22
pt recieved pneumovax in left deltoid yesterday, started huring at night, not able to sleep. 6/ 10 pain- burning. radiates to shoulder, difficult to move arm, swollen. left arm cellulitis- rx for cephalexin, naproxen, alternating with otc tylenol, elevate arm, cool compress, er if worsens. right bicep 28 cm, right bicep 32 cm- +surgical scar, + swollen + warmth/ erythema
TINNITUS LEFT EAR - SUDDENLY 10 Days AGO - SEVERE -  KEEPS LIP @ NIGHT
high blood pressure; headache; red rash on arm above elbow; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (high blood pressure), RASH ERYTHEMATOUS (red rash on arm above elbow) and HEADACHE (headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Hypertension and Cholesterol. Concomitant products included COLECALCIFEROL (VITAMIN D 3) and POTASSIUM for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced RASH ERYTHEMATOUS (red rash on arm above elbow). On an unknown date, the patient experienced HYPERTENSION (high blood pressure) and HEADACHE (headache). At the time of the report, HYPERTENSION (high blood pressure), RASH ERYTHEMATOUS (red rash on arm above elbow) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to MOD-2021-020519 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Feb-2021: No specific follow-up information recorded.
20 minutes after receiving the vaccine, felt lightheaded, felt like having a Bn, had diarrhea, went to ER. After lying down on gurney felt better. Had a rash, felt flushed, heat rash. Felt nauseated after sitting up. Started an IV on her. No SOB, felt like a lump in throat. Received Benadryl, Pepcid, Solucortef. Was on Prednisone and Pepcid.
Sick like a dog; Sweating; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick like a dog) and HYPERHIDROSIS (Sweating) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 036B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-May-2021, the patient experienced ILLNESS (Sick like a dog) and HYPERHIDROSIS (Sweating). On 14-May-2021, ILLNESS (Sick like a dog) and HYPERHIDROSIS (Sweating) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jun-2021, White blood cell count: 16000 (High) increased.         Concomitant medication was not reported.  Treatment information was not provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
No adverse event; reported that they inadvertently administered 40 doses of the monovalent vaccines/ expiration date 13Jul2022 Date of administration of vaccines were on 26Jul2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (reported that they inadvertently administered 40 doses of the monovalent vaccines/ expiration date 13Jul2022 Date of administration of vaccines were on 26Jul2022) and NO ADVERSE EVENT (No adverse event) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M21A, FF8839 and EW0186) for COVID-19 prophylaxis.     No Medical History information was reported.   On 02-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jul-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (reported that they inadvertently administered 40 doses of the monovalent vaccines/ expiration date 13Jul2022 Date of administration of vaccines were on 26Jul2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (reported that they inadvertently administered 40 doses of the monovalent vaccines/ expiration date 13Jul2022 Date of administration of vaccines were on 26Jul2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (reported that they inadvertently administered 40 doses of the monovalent vaccines/ expiration date 13Jul2022 Date of administration of vaccines were on 26Jul2022).    No concomitant product reported by reporter. Pharmacy staff reported that they inadvertently administered 51 doses of the monovalent vaccines. Lot number 004M21A, expiration date 13Jul2022 Date(s) of administration of vaccine were 26Jul2022 (40 doses), 04Aug2022 (1 dose), 19Aug2022 (1 dose), 30Sep2022 (1 dose). No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704260, US-MODERNATX, INC.-MOD-2023-704260 ( Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704260:(Master case) US-MODERNATX, INC.-MOD-2023-704260:
Pt states they experienced arm pain and stiffness that lingered for months after the dose. Immediate effects limited mobility for a brief period after the dose.
pt recv 3 doses of MMR in 1968, 1972, 1980 & lab eval revealed a negative antibody;no further details were provided;
The next morning I woke up with a feeling of clogged ears. It was hard to hear. Feeling for better over the last few days but now on the 7th day I can barely hear out of my right ear. Have been trying to ?pop? my ears to relieve pressure. Nothing helps. Slight ringing in my right ear as well.
Information has been received from a pharmacist, via company representative, concerning a female patient of an unspecified age a little over 50 years old. The patient had no pertinent medical history, previously drug reactions, allergies or concurrent conditions reported. Her concomitant medications included an unspecified high blood pressure medication. On an unknown date in March 2019 (reported as: "earlier this week"), the patient was vaccinated with one dose of PNEUMOVAX 23 (strength, dose number, anatomical location, route of administration, lot number and expiration date were not provided), as prophylaxis. Right after PNEUMOVAX 23 vaccination, the patient experienced a "allergic reaction" (type I hypersensitivity); the pharmacist reported the patient also developed a fever and could not breath (dyspnoea) for a few minutes. It took an hour for the patient to fully recover. At the time of the report, it was unknown if patient sought medical attention, if laboratory diagnostics or studies were performed or if she received treatment for the adverse events. The causal relationship between aforementioned adverse events and PNEUMOVAX 23 was not reported. Upon internal review, the type I hypersensitivity was considered a medically significant event.
Tested positive for Covid-19 on 09Jul2022; began treatment with Paxlovid that afternoon; Tested positive for Covid-19 on 09Jul2022; began treatment with Paxlovid that afternoon; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 13Apr2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 27Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 61 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 12Apr2022 at 16:00 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant) with onset 09Jul2022, outcome "unknown", COVID-19 (medically significant) with onset 09Jul2022, outcome "not recovered" and all described as "Tested positive for Covid-19 on 09Jul2022; began treatment with Paxlovid that afternoon". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09Jul2022) Positive; (18Jul2022) Positive; (17Jul2022) Negative; (25Jul2022) Positive, notes: As of today 25Jul2022 I have intermittent cough, fatigue, stuffy runny nose and still testing positive on a home Covid test. Therapeutic measures were taken as a result of covid-19.  Clinical course: The patient was received covid vaccine treatment. She was no pregnant and occupation None of the above. The patient was no Other medication in 2weeks.The vaccine lot unknown reason other Can't find vax card. The patient was not recovered. The patient was no received other medication treatment and unknown allergies was reported.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced HEADACHE (Headaches). The patient was treated with PARACETAMOL (TYLENOL) ongoing from 15-Apr-2021 for Headache, at a dose of 1 dosage form. At the time of the report, HEADACHE (Headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Vaccine given on 9/14/17 in clinic per protocol without any adverse event. Pt came to clinic on 10/4/17 complaining of rash that started a "few days" prior. Rash: Splotchy on abdomen, scratches on upper thighs. Painful in both areas. Both started at the same time. Not itchy, it "burns". No new medications, soaps, lotions, foods. Unable to identify any triggers. Consulted with MD, Diagnosed with contact dermatitis and treated with Bethamethasone topical cream 0.05% BID x 5 days. Client called clinic on 10/23/17 stating that she figured out the trigger for the rash and feels it is related to the Hepatitis B vaccination.
pt recvd vax & felt heavy feeling in head; BP 180/50; pt had flu like symptoms; t 102; nausea; body aches; low grade fever;
Dizziness at 5 to ten minutes of injection , elevated blood pressure. Dizziness was improving after 30 minutes so I was allowed to leave the vaccination facility  shortness of Breath  started 35 o 40 minutes after injection.   When I was was walking  out to my car   My daughter was in area and picked me up and she had Benadryl Took 2 Benadryl   Shortness of breath started to improve after An hour of Benadryl. Hoarse voice improved some but continued to improve after second dose of Benadryl.  Now on March 11 I still have a slight hoarse voice but so much better. I?ve been taking Benadryl every 4 to 6 hours regularly per my Dr  I don?t have shortness of breath anymore but my chest does feel a little tight
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions and medical history were not reported. In approximately 2016 (reported as on or after 08-APR-2016), the patients were vaccinated with improperly stored does of VARIVAX lot # L044527, expiration date reported as 09-NOV-2017 (dose, route and site of administration were not reported). There was no adverse effect reported. Administered doses of vaccine experienced the temperature excursion for 110 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Normally, patient has neuropathy but it has never been this bad before and it has never been that high up.; Terrible cramps in both legs and thighs; This is a spontaneous report from a contactable consumer who reported for herself, a 93-year-old female patient who received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3248), via an unspecified route of administration on 15Jan2021, at the age of 93 years, at a single dose for COVID-19 immunization. Medical history included diabetes and neuropathy, both ongoing. Concomitant medications included unspecified medicines including one for diabetes. The patient stated that she received her shot yesterday, 15Jan2021 and last night, same day of vaccination 15Jan2021, she had terrible cramps in both legs and thighs and was just wondering if that was one of the symptoms. Normally, patient has neuropathy but it has never been this bad before and it has never been that high up (15Jan2021). The outcome of the events was unknown.
Patient complained of dizziness about 5 minutes after vaccinations. Patient was still conscious coherent. Patient was advised to remain seated and was given water and orange juice. Patient recovered within 5 to 10 minutes.
Redness, induration, soreness, skin hot to touch, area around vaccine with positive swelling (width -  2x 4  " Length)  to be monitored x 24 hours .   Emergency room if symptoms worsens.
ambulance to ER 1842 hrs on 20MAY92 fever 104, had started 1 hrs p/shot @ 102 & went to 105 that noc; waived between 102-105; febrile seizure @ home then called ambulance went to ER;
This report from study was reported via Pregnancy Registry (initial receipt 19-Aug-2015) concerns a neonate patient. Concomitant medications, received via the mother in utero, included unspecified prenatal vitamins, salmeterol/fluticasone, estradiol, progesterone, calcium carbonate, and DTP vaccine. The patient's mother had a medical history of asthma (diagnosed in 1982), pulmonary embolism (diagnosed in 2004), endometriosis and other uterine disorder, heartburn, and secondary infertility requiring salpingectomy (in 2009) in left tube due to hydrosalpinx. (Refer to the mother case: 2015053328). On 02-Oct-2013, the patient received AFLURIA (batch number R54507) from the mother, in-utero. The patient's mother underwent multiple ultrasound scans, multiple non-stress/stress tests, and alpha-fetoprotein test which were all normal during the course of her pregnancy. The first trimester serum screen was done on 10-Sep-2013. The patient was born at the gestational age of 39.6 (patient's weight 3920.0 grams, Apgars at 1 min: 9, Apgar at 5 min: 9). The patient was diagnosed with vascular malformation (port wine stain) 3.6 x 2.7 cm on mid-chin extending to the right cheek (extension onto the cheek in 2.5 cm) with no involvement of V1, unilateral involvement. This was present since birth with no changes (color, size, shape) and no bleeding. At 4 weeks (on 15-Apr-2014), the patient was well. No further evaluation was required but laser treatment was available. The outcome was not reported.
almost fainting; felt weak; Dizzy; terrible headache; unsteady; diarrhea; Rash on her arm; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (almost fainting), ASTHENIA (felt weak), DIZZINESS (Dizzy), HEADACHE (terrible headache) and BALANCE DISORDER (unsteady) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PRESYNCOPE (almost fainting), ASTHENIA (felt weak), DIZZINESS (Dizzy), HEADACHE (terrible headache), BALANCE DISORDER (unsteady), DIARRHOEA (diarrhea) and VACCINATION SITE RASH (Rash on her arm). At the time of the report, PRESYNCOPE (almost fainting), ASTHENIA (felt weak), DIZZINESS (Dizzy), HEADACHE (terrible headache), BALANCE DISORDER (unsteady), DIARRHOEA (diarrhea) and VACCINATION SITE RASH (Rash on her arm) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: Upon internal review on 27-Sep-2022, non-significant correction was performed to update case level seriousness.; Reporter's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested.
Patient's arm is swollen and red from injection site and several inches around . It is becoming more painful and irritating each day since the vaccine was administered on 9/10.
PATIENT WAS ADMINISTERED 4 VACCINES.  WITH EACH NEEDLE STICK HE FLINCHED AND TENSED UP.  THE 4TH VACCINE ADMINISTERED WAS VARICELLA.  WITH NEEDLE STICK, HE FAINTED.  HE WAS SEATED ON THE EXAM TABLE AT THE TIME.  WHEN HE FAINTED, I WAS EASILY ABLE TO SUPPORT HIM AND LOWER HIM FLAT ON HIS BACK.  HE RECOVERED AFTER ABOUT 15 SECONDS AND WAS ALERT AND ORIENTATED X3 BUT STILL A LITTLE GROGGY AND PALE.  HE WAS KEPT IN THE SUPINE POSITION WITH A COOL WASH CLOTH AND MONITORED FOR 15 MINUTES AT WHICH POINT HE FELT MUCH BETTER, COLOR WAS BETTER, AND NEUROLOGICAL AND MENTAL STATUS EXAMS WERE NORMAL.
Injection administered on 11/5/12, patient called today, 11/9/12 to report adverse reaction of swelling at injection site. Which the patient went to the hospital for on 11/7/12.
pt admitted w/ respiratory failure 2/2 covid pna, fully vaccinated. tx w remdesivir, dexamethasone, o2
Pt. was given expired vaccine. Vaccine expired on 12/22/2020 and given on 1/12/2021.